{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,11,16]],"date-time":"2024-11-16T11:10:32Z","timestamp":1731755432504,"version":"3.28.0"},"reference-count":9,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,11,16]]},"DOI":"10.7759\/cureus.73794","type":"journal-article","created":{"date-parts":[[2024,11,16]],"date-time":"2024-11-16T10:40:33Z","timestamp":1731753633000},"source":"Crossref","is-referenced-by-count":0,"title":["A Case Report of Atypical Presentation of Metastatic Breast Cancer as Peri-Bronchial Mediastinal Lesion"],"prefix":"10.7759","author":[{"given":"Sarah","family":"Tseu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sadathulla","family":"Sharief","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Syed","family":"Mehdi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"Breast cancer incidence (invasive) statistics. (2015). Accessed.  August 5, 2024: https:\/\/www.cancerresearchuk.org\/health-professional\/cancer-statistics\/statistics-by-cancer-type\/breast-cancer\/incide...."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.canep.2017.04.010","article-title":"Typical and atypical presenting symptoms of breast cancer and their associations with diagnostic intervals: evidence from a national audit of cancer diagnosis","volume":"48","author":"Koo MM","year":"2017","unstructured":"Koo MM, von Wagner C, Abel GA, McPhail S, Rubin GP, Lyratzopoulos G. Typical and atypical presenting symptoms of breast cancer and their associations with diagnostic intervals: evidence from a national audit of cancer diagnosis. Cancer Epidemiol. 2017, 48:140-6. 10.1016\/j.canep.2017.04.010","journal-title":"Cancer Epidemiol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.2147\/BCTT.S432526","article-title":"Breast cancer: an overview of current therapeutic strategies, challenge, and perspectives","volume":"15","author":"Wang J","year":"2023","unstructured":"Wang J, Wu SG. Breast cancer: an overview of current therapeutic strategies, challenge, and perspectives. Breast Cancer (Dove Med Press). 2023, 15:721-30. 10.2147\/BCTT.S432526","journal-title":"Breast Cancer (Dove Med Press)"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djab202","article-title":"The incidence of breast cancer recurrence 10-32 years after primary diagnosis","volume":"114","author":"Pedersen RN","year":"2022","unstructured":"Pedersen RN, Esen B\u00d6, Mellemkj\u00e6r L, et al.. The incidence of breast cancer recurrence 10-32 years after primary diagnosis. J Natl Cancer Inst. 2022, 114:391-9. 10.1093\/jnci\/djab202","journal-title":"J Natl Cancer Inst"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.22804","article-title":"Very late recurrence in breast cancer: is breast cancer a chronic disease?","volume":"14","author":"Kamata A","year":"2022","unstructured":"Kamata A, Hino K, Kamiyama K, Takasaka Y. Very late recurrence in breast cancer: is breast cancer a chronic disease?. Cureus. 2022, 14:e22804. 10.7759\/cureus.22804","journal-title":"Cureus"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.62.3504","article-title":"Annual hazard rates of recurrence for breast cancer during 24 years of follow-up: results from the International Breast Cancer Study Group trials I to V","volume":"34","author":"Colleoni M","year":"2016","unstructured":"Colleoni M, Sun Z, Price KN, et al.. Annual hazard rates of recurrence for breast cancer during 24 years of follow-up: results from the International Breast Cancer Study Group trials I to V. J Clin Oncol. 2016, 34:927-35. 10.1200\/JCO.2015.62.3504","journal-title":"J Clin Oncol"},{"key":"ref7","unstructured":"NICE. Early and locally advanced breast cancer. diagnosis and management. (2018). Accessed: September 7, 2024: https:\/\/www.nice.org.uk\/guidance\/ng101\/chapter\/Recommendations."},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1607303","article-title":"Palbociclib and letrozole in advanced breast cancer","volume":"375","author":"Finn RS","year":"2016","unstructured":"Finn RS, Martin M, Rugo HS, et al.. Palbociclib and letrozole in advanced breast cancer. N Engl J Med. 2016, 375:1925-36. 10.1056\/NEJMoa1607303","journal-title":"N Engl J Med"},{"key":"ref9","unstructured":"National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology. Breast cancer. (2024). Accessed. November 5, 2024: https:\/\/www.nccn.org\/guidelines\/guidelines-detail?category=1&id=1419."}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/301771-a-case-report-of-atypical-presentation-of-metastatic-breast-cancer-as-peri-bronchial-mediastinal-lesion","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,16]],"date-time":"2024-11-16T10:40:35Z","timestamp":1731753635000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/301771-a-case-report-of-atypical-presentation-of-metastatic-breast-cancer-as-peri-bronchial-mediastinal-lesion"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,16]]},"references-count":9,"URL":"https:\/\/doi.org\/10.7759\/cureus.73794","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11,16]]}}}